Post Tagged with: "Treatment"

Editor’s Pick: Renal Involvement in Multiple Myeloma

Editor’s Pick: Renal Involvement in Multiple Myeloma

European Medical Journal, Oncology August 31, 2017 at 8:24 AM 0 comments

Fifteen years ago, renal involvement and renal failure were almost inevitable consequences of multiple myeloma, dramatically impacting survival and quality of life. Since the introduction of innovative drugs (the so called ‘new drugs’ and ‘newer drugs’), autologous haemopoietic cell transplantations, and the innovative technique of light chain removal, myeloma outcomesRead More

Peyronie’s Disease: Recent Treatment Modalities

Peyronie’s Disease: Recent Treatment Modalities

European Medical Journal, Urology August 31, 2017 at 8:22 AM 0 comments

Ali Can Albaz, *Oktay Üçer Department of Urology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey *Correspondence to uceroktay@yahoo.com Disclosure: The authors have declared no conflicts of interest. Received: 17.01.17 Accepted: 26.04.17 Citation: EMJ. 2017;2[3]:63-70. Abstract Peyronie’s disease (PD), which is characterised by fibrous plaque formation in the tunica albugineaRead More

Paediatric Primary Headache: Pharmacological and Non-Pharmacological Treatments

Paediatric Primary Headache: Pharmacological and Non-Pharmacological Treatments

Neurology August 10, 2017 at 8:27 AM 0 comments

*Jacob Genizi,1,2 Isaac Srugo,2 Nurit Assaf,1 Nogah C. Kerem2,3 1. Pediatric Neurology Unit, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 2. Pediatric Department, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 3. Adolescent Medicine Unit, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelRead More

Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Allergy & Immunology August 3, 2017 at 8:21 AM 0 comments

Zhi-qiang Tu, *Wei-qi Zhang Department of Pediatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China *Correspondence to zhangwq2016@126.com Disclosure: The authors have declared no conflicts of interest. Received: 02.02.17 Accepted: 16.06.17 Citation: EMJ Allergy and Immunol. 2017;2[1]:100-105. Abstract One of the complications of systemic juvenile idiopathic arthritis (SJIA)Read More

New Drug Treatments for Osteoarthritis: What is on the Horizon?

New Drug Treatments for Osteoarthritis: What is on the Horizon?

*Fiona E. Watt,1 Malvika Gulati2 1. Arthritis Research UK Centre for Osteoarthritis Pathogenesis, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK 2. Department of Rheumatology, Royal Free Hospital, London, UK *Correspondence to fiona.watt@kennedy.ox.ac.uk Disclosure: The authors have declared no conflicts of interest. Support:Read More

Cirrhosis: Reviewing the Literature and Future Perspectives

Cirrhosis: Reviewing the Literature and Future Perspectives

European Medical Journal August 23, 2016 at 8:17 AM 0 comments

*Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium *Correspondence to xavier.verhelst@uzgent.be Disclosure: The authors have declared no conflicts of interest. Received: 07.01.16 Accepted: 09.02.16 Citation: EMJ. 2016;1[3]:111-117. Abstract Cirrhosis is the final stage of chronic liver disease and has many causes,Read More

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Hematology July 28, 2016 at 8:20 AM 0 comments

*Xavier Thomas, Caroline Le Jeune Hematology Department, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France *Correspondence to xavier.thomas@chu-lyon.fr Disclosure: The authors have declared no conflicts of interest. Received: 21.03.16 Accepted: 28.06.16 Citation: EMJ Hematol. 2016;4[1]:117-128. Abstract Less than 50% of patients with adult acute lymphoblastic leukaemia (ALL)Read More

Editor’s Pick: Clinical Significance of Apathy in Parkinson’s Disease

Editor’s Pick: Clinical Significance of Apathy in Parkinson’s Disease

Neurology July 12, 2016 at 8:28 AM 0 comments

The significant health burden that apathy creates for patients with Parkinson’s disease is  revealed in the following article by Muhammed and Husain; also highlighted are the difficulties of a therapeutic approach towards tackling a lack of motivation. This is an important issue for clinical neurologists who must be careful notRead More

Development and Translation of Therapies for Spinal Muscular Atrophy

Development and Translation of Therapies for Spinal Muscular Atrophy

Neurology July 12, 2016 at 8:27 AM 0 comments

Hannah K. Shorrock, *Thomas H. Gillingwater Euan MacDonald Centre for Motor Neurone Disease Research and Centre for Integrative Physiology, University of Edinburgh, Edinburgh, UK *Correspondence to t.gillingwater@ed.ac.uk Disclosure: The authors have declared no conflicts of interest. Received: 27.01.16 Accepted: 01.06.16 Citation: EMJ Neurol. 2016;4[1]:64-73. Abstract Spinal muscular atrophy (SMA) isRead More

Treating the Diabetic Hypertensive: Consensus and Differences

Treating the Diabetic Hypertensive: Consensus and Differences

Diabetes, Nephrology July 5, 2016 at 8:21 AM 0 comments

*Abdul Rashid Rahman An Nur Specialist Hospital, Bandar Baru Bangi, Selangor, Malaysia *Correspondence to abdulrashid43000@gmail.com Disclosure: The author has declared no conflicts of interest. Received: 29.02.16 Accepted: 31.05.16 Citation: EMJ Nephrol. 2016;4[1]:98-104. Abstract Hypertension and diabetes commonly coexist. Both are major modifiable risk factors for cardiovascular diseases. There has beenRead More